Africa’s EVA Pharma, France’s DNA Script, and Belgium’s Quantoom Biosciences have signed a Memorandum of Understanding which ...

Vaccines are critical to disease prevention and infection control ... types of challenges by researching self-amplifying RNA (saRNA) and novel antigen-design technologies. saRNA is a novel vaccine ...

French company DNA Script will contribute its enzymatic DNA synthesis technologies, while Quantoom of Belgium will bring its ...

While some of the initial zeal around localized vaccine production in Africa has waned since the height of the COVID-19 pandemic, efforts to bolster the continent’s immunization autonomy—especially | ...

Harnessing the targeted gene manipulation in cells enabled by ChaESAR, Chimeron is developing a compelling portfolio of innovative saRNA-based vaccines and therapeutics for infectious diseases ...

Sarna spent the past year as a visiting partner ... which looked to manufacture devices that could detect the deadly disease in a woman’s fallopian tubes. “It took me a year and 50-plus ...